MARTINELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.070
EU - Europa 437
AS - Asia 351
AF - Africa 22
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.884
Nazione #
US - Stati Uniti d'America 1.057
IT - Italia 212
SG - Singapore 170
CN - Cina 137
NL - Olanda 76
IN - India 34
FI - Finlandia 32
IE - Irlanda 32
CI - Costa d'Avorio 22
DE - Germania 22
UA - Ucraina 16
SE - Svezia 15
CA - Canada 12
GB - Regno Unito 11
FR - Francia 5
RU - Federazione Russa 4
ES - Italia 3
IR - Iran 3
PL - Polonia 3
PT - Portogallo 3
EC - Ecuador 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TR - Turchia 1
Totale 1.884
Città #
Chandler 181
Singapore 139
Ashburn 81
Amsterdam 74
Millbury 65
Beijing 46
Seattle 45
Naples 41
Des Moines 37
Princeton 33
Santa Clara 33
Boston 32
Napoli 31
Nanjing 28
Lawrence 24
Pune 16
Woodbridge 15
Jacksonville 13
Augusta 12
Nanchang 11
Wilmington 11
Milan 10
Lappeenranta 9
Shenyang 8
Changsha 7
Ottawa 7
Rome 7
San Mateo 7
Kronberg 6
Los Angeles 6
Dallas 5
Hebei 5
Jiaxing 5
Boardman 4
Dublin 4
Toronto 4
Houston 3
Montecorvino Rovella 3
Oristano 3
Villaricca 3
Wuhan 3
Barcelos 2
Casal di Principe 2
Falls Church 2
Gdansk 2
Groningen 2
Guangzhou 2
Leawood 2
London 2
Moncalieri 2
Moscow 2
Norwalk 2
Palermo 2
Rajakkapatti 2
Redwood City 2
Sant'agnello 2
Scafati 2
Stockholm 2
Tianjin 2
Turin 2
A Coruña 1
Al Ain City 1
Alexandria 1
Amherst 1
Ann Arbor 1
Bandar Seri Begawan 1
Bengaluru 1
Bogen 1
Bologna 1
Brusciano 1
Cagliari 1
Campiglia Marittima 1
Capua 1
Carpi 1
Carugate 1
Caserta 1
Chicago 1
Cutrofiano 1
Duncan 1
Esslingen am Neckar 1
Fairfield 1
Ferrara 1
Fremont 1
Guadalajara 1
Guayaquil 1
Gunzenhausen 1
Hangzhou 1
Kaifeng 1
Kunming 1
Lisbon 1
Madrid 1
Manila 1
Marigliano 1
Mexico City 1
Mumbai 1
Munich 1
Nagold 1
Nantong 1
New York 1
Pagani 1
Totale 1.155
Nome #
Effect of Magnesium Alginate Plus Simethicone on Gastroesophageal Reflux in Infants 71
PP-12 EFFICACY OF A STANDARDIZED EXTRACT OF MATRICARIAE CHAMOMILLA L., MELISSA OFFICINALIS L. AND TYNDALLIZED LACTOBACILLUS ACIDOPHILUS (H122) COMPARED WITH LACTOBACILLUS REUTERI (DSM 17938) AND WITH SIMETHICONE FOR THE TREATMENT OF INFANTILE COLIC 70
Natural history of pancreatic involvement in paediatric inflammatory bowel disease 69
20 mm lithium button battery causing an oesophageal perforation in a toddler: Lessons in diagnosis and treatment 67
The Changing Face of Pediatric Ulcerative Colitis: A Population-based Cohort Study 60
Yersinia Enterocolitica Ileitis Mimicking Pediatric Crohn's Disease 48
Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study 48
Impact of the Rome II paediatric criteria on the appropriateness of the upper and lower gastrointestinal endoscopy in children. 47
Improvement of body composition and bone mineral density after enteral nutrition in pediatric Crohn disease 43
Efficacy of a standardized extract of Matricariae chamomilla L., Melissa officinalis L. and tyndallized Lactobacillus acidophilus (HA122) in infantile colic: An open randomized controlled trial 42
Effectiveness of mediterranean diet’s adherence in children with inflammatory bowel diseases 42
Impact of hiatal hernia on pediatric dyspeptic symptoms 41
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 41
An Altered Gut Microbiome Profile in a Child Affected by Crohn's Disease Normalized After Nutritional Therapy 38
Diagnostic and therapeutic utility of double-balloon enteroscopy in children 38
Il trattamento dei disordini funzionali gastrointestinali: Farmaci, fibre, probiotici, terapia comportamentale o altro? 37
Exclusive enteral nutrition effect on the clinical course of pediatric Crohn’s disease: a single center experience 37
Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis? 36
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease 36
The role of inflammation on Vitamin D levels in a cohort of pediatric patients with Inflammatory Bowel Disease 36
Clostridium difficile and Pediatric Inflammatory Bowel Disease 35
Do distinct functional dyspepsia subtypes exist in children? 35
Impact of Environmental and Familial Factors in a Cohort of Pediatric Patients with Inflammatory Bowel Disease 35
Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic 35
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 34
Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN 33
Autophagy genes variants and pediatric Crohn's disease phenotype: a single-center experience. 31
Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. 30
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report 30
Stool Consistency, but Not Frequency, Correlates with Total Gastrointestinal Transit Time in Children 29
Paediatric ulcerative colitis surgery: Italian survey 29
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis 29
Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. 28
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis 28
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 25
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN 25
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 25
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease 24
Novel and alternative therapies for childhood constipation 23
Motility Problems in the Intellectually Challenged Child, Adolescent, and Young Adult 23
Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children 23
Colonic Function Investigations in Children: Review by the ESPGHAN Motility Working Group 22
Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task 20
Prescribing patterns, indications and adverse events of ibuprofen in children: results from a national survey among Italian pediatricians 20
Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic 20
Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. 19
Poly(C)- binding protein Pcbp2 enables differentiation of definitive erythropoiesis by directing functional splicing of the Runx1 transcript 19
Implications of splicing alterations in the onset and phenotypic variability of a family with subclinical manifestation of Peutz–Jeghers syndrome: Bioinformatic and molecular evidence 19
The ten “hard” questions in pediatric functional constipation 18
Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care 18
Overall Impact of COVID-19 Outbreak in Children with Functional Abdominal Pain Disorders: Results From the First Pandemic Phase 18
The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study 17
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 17
Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease During COVID-19 Pandemic: A Prospective Study 16
Foreign body and caustic ingestions in children: A clinical practice guideline: Foreign Bodies and Caustic ingestions in children 16
Infliximab therapy decreases the expression of serum and faecal miR‐126 and miR‐20a in paediatric Crohn's disease: A pilot study 15
Probiotics' efficacy in paediatric diseases: Which is the evidence? A critical review on behalf of the Italian Society of Pediatrics 15
Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease 14
Erratum: Probiotics' efficacy in paediatric diseases: Which is the evidence? A critical review on behalf of the Italian Society of Pediatrics (Ital J Pediatr. (2020) 46 (104) DOI: 10.1186/s13052-020-00862-z) 14
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 13
Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis 13
Prevalence of functional gastrointestinal disorders in children with celiac disease on different types of gluten-free diets 12
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 12
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response 11
The poly(C)-binding protein Pcbp2 is essential for CD4+ T cell activation and proliferation 11
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 11
Diagnosis and management of anemia in pediatric inflammatory bowel diseases: Clinical practice guidelines on behalf of the SIGENP IBD Working group 10
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 10
De Novo Crohn’s Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch–Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN 8
Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn’s Disease 8
Severe upper gastrointestinal involvement in paediatric ulcerative colitis 8
Surgical Complications Need to Be Carefully Excluded Before Ruling Out a Diagnosis of De Novo Crohn’s Disease 7
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 6
Impact of Coronavirus disease 2019 pandemic in children with functional abdominal pain disorders: Data from long‐term follow‐up 6
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group 5
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 5
Endoscopic Balloon Dilatation in Pediatric Crohn Disease: An IBD Porto Group Study 4
Totale 2.033
Categoria #
all - tutte 10.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 22 2 1 3 19 30 21 6
2020/2021153 5 3 6 8 25 12 16 17 8 12 39 2
2021/2022328 7 0 0 2 11 6 7 7 31 21 89 147
2022/2023506 58 30 18 24 68 49 7 58 86 62 36 10
2023/2024444 16 60 29 20 19 76 2 83 19 12 73 35
2024/2025225 100 54 4 21 46 0 0 0 0 0 0 0
Totale 2.033